UTHR
United Therapeutics Corporation
Stock
$541.70−29.68 (−5.19%)Close Oct 2, 2026
- Operating cash flow, 2025
- $1.6B
- YoY, 2025
- +17.6%
- 5-year CAGR
- +15.6%
- 10-year CAGR
- +15.1%
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | $1.6B | +17.6% |
| 2024 | $1.3B | +35.7% |
| 2023 | $978M | +21.9% |
| 2022 | $803M | +34.2% |
| 2021 | $598M | −20.8% |
| 2020 | $756M | — |
| 2019 | −$207M | — |
| 2018 | $778M | +64.2% |
| 2017 | $474M | −26.3% |
| 2016 | $644M | +68.1% |
| 2015 | $383M | +7.7% |
| 2014 | $355M | −16.5% |
| 2013 | $425M | +31.4% |
| 2012 | $324M | +29.4% |
| 2011 | $250M | +18.3% |
| 2010 | $212M | +112.1% |
| 2009 | $100M | — |
| 2008 | −$40M | — |